|
|
Article: Neurocrine Biosciences Announces Study Showing Indiplon Immediate Release Safe for Middle of the Night Dosing Without Next Day Residual Effects; Data Presented at the American Psychiatric Association (APA) Meeting.
- Article from:
- PR Newswire
- Article date:
- May 4, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Neurocrine Biosciences, Inc. announced results from a study in healthy volunteers presented today that shows that indiplon immediate release when taken in the middle of the night (MOTN) is safe and well tolerated without evidence of next day residual effects. These results were presented at the 157th annual meeting of the American Psychiatric Association (APA) in New York City.
"This is promising data for patients who have trouble staying asleep and wake up frequently in the middle of the night. They are often concerned that taking a sleep medication will leave them feeling groggy the next day," said Dr. Marty Scharf, Director, Tri-State Sleep Disorders Center ...